Inventor · disambiguated record
Shaker A. Mousa
Also filed as: MOUSA SHAKER · MOUSA SHAKER A · MOUSA SHAKER AHMED
68 granted patents·24 pending applications·767 citations·filing 1994–2021
99Inventor score
Top patents by PatentIndex Score
92 records- 0198US8668926B1Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereofMOUSA SHAKER A·Filed 2007·Granted Mar 11, 2014·95 cites·6 claims
- 0296US10961204B1Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumorsNANOPHARMACEUTICALS LLC·Filed 2020·Granted Mar 30, 2021·4 cites·18 claims
- 0396US8802240B2Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cellsDAVIS PAUL J·Filed 2012·Granted Aug 12, 2014·29 cites·27 claims
- 0496US8071134B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2005·Granted Dec 6, 2011·27 cites·4 claims
- 0595US9579300B2Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereofNANOPHARMACEUTICALS LLC·Filed 2014·Granted Feb 28, 2017·13 cites·19 claims
- 0695US9498536B2Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disordersNANOPHARMACEUTICALS LLC·Filed 2014·Granted Nov 22, 2016·16 cites·23 claims
- 0794US10993909B1Method and composition for treating upper respiratory tract inflammatory and infectious diseasesVirothera Pharmaceuticals LLC·Filed 2020·Granted May 4, 2021·6 cites·30 claims
- 0894US10130686B2Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disordersNANOPHARMACEUTICALS LLC·Filed 2016·Granted Nov 20, 2018·7 cites·20 claims
- 0994US9750709B2Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereofNANOPHARMACEUTICALS LLC·Filed 2014·Granted Sep 5, 2017·11 cites·13 claims
- 1094US9198887B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2013·Granted Dec 1, 2015·16 cites·6 claims
- 1193US8518451B2Thyroid hormone analogs and methods of useMOUSA SHAKER A·Filed 2009·Granted Aug 27, 2013·21 cites·3 claims
- 1293US7741311B2Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healingMOUSA SHAKER·Filed 2006·Granted Jun 22, 2010·13 cites·57 claims
- 1392US6815426B2Angiogenesis-inhibitory tripeptides, compositions and their methods of useDU PONT·Filed 2002·Granted Nov 9, 2004·33 cites·23 claims
- 1491US8481479B1Formulations of factor VIIa inhibitors and utilityMOUSA SHAKER A·Filed 2012·Granted Jul 9, 2013·10 cites·7 claims
- 1590US10947220B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2020·Granted Mar 16, 2021·2 cites·7 claims
- 1690US10328043B1Composition and method for dual targeting in treatment of neuroendocrine tumorsNANOPHARMACEUTICALS LLC·Filed 2018·Granted Jun 25, 2019·11 cites·21 claims
- 1790US10131637B2Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Nov 20, 2018·10 cites·6 claims
- 1890US9839614B2Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereofNANOPHARMACEUTICALS LLC·Filed 2015·Granted Dec 12, 2017·9 cites·13 claims
- 1990US8071569B2Oxidized heparin fractions and their use in inhibiting angiogenesisMOUSA SHAKER A·Filed 2011·Granted Dec 6, 2011·15 cites·19 claims
- 2090US6022523ARadiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disordersDU PONT PHARM CO·Filed 1997·Granted Feb 8, 2000·46 cites·1 claims
- 2189US9289395B2Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereofDAVIS PAUL J·Filed 2010·Granted Mar 22, 2016·16 cites·20 claims
- 2289US9180107B2Combination treatment of cancer with cetuximab and tetracLIN HUNG-YUN·Filed 2010·Granted Nov 10, 2015·16 cites·21 claims
- 2388US8232428B2Polycationic compounds and uses thereofMOUSA SHAKER·Filed 2010·Granted Jul 31, 2012·10 cites·20 claims
- 2487US10201616B2Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonistsNANOPHARMACEUTICALS LLC·Filed 2017·Granted Feb 12, 2019·6 cites·23 claims
- 2587US9272049B2Methods of stimulating fat mobilization using a polymer conjugated polyphenolALEXANDER-BRIDGES MARIA·Filed 2011·Granted Mar 1, 2016·15 cites·5 claims
- 2687US9220788B2Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereofDAVIS PAUL J·Filed 2010·Granted Dec 29, 2015·18 cites·31 claims
- 2786US9655862B2Ocular nanoformulation and method of use in angiogenesis-mediated disordersMOUSA SHAKER A·Filed 2014·Granted May 23, 2017·3 cites·24 claims
- 2886US8404281B2FormulationsRUBIN LEO·Filed 2010·Granted Mar 26, 2013·4 cites·23 claims
- 2986US8129566B2Polycationic compounds and uses thereofMOUSA SHAKER·Filed 2010·Granted Mar 6, 2012·7 cites·9 claims
- 3086US7785632B2Thyroid hormone analogs and methods of useORDWAY RES INST INC·Filed 2004·Granted Aug 31, 2010·24 cites·4 claims
- 3186US5849736AIsoxazoline and isoxazole fibrinogen receptor antagonistsDU PONT MERCK PHARMA·Filed 1995·Granted Dec 15, 1998·70 cites·31 claims
- 3285US11077082B2Composition and method for dual targeting in treatment of neuroendocrine tumorsNANOPHARMACEUTICALS LLC·Filed 2019·Granted Aug 3, 2021·2 cites·22 claims
- 3385US9682085B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2014·Granted Jun 20, 2017·4 cites·5 claims
- 3485US8507723B2Polycationic compounds and uses thereofMOUSA SHAKER·Filed 2012·Granted Aug 13, 2013·5 cites·13 claims
- 3579US8968790B2Nanoformulation of vitamin D derivatives and/or vitamin D metabolitesMOUSA SHAKER A·Filed 2012·Granted Mar 3, 2015·9 cites·27 claims
- 3678US10899748B2Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and methods of using the same in the treatment and/or prevention of cardiovascular diseasesSHIFA BIOMEDICAL CORP·Filed 2017·Granted Jan 26, 2021·2 cites·5 claims
- 3778US10046005B2Composition and method of use for combinations of anti-viral protease, polymerase inhibitors and natural bioactive compounds in the treatment of hepatitis C infectionMOUSA SHAKER A·Filed 2016·Granted Aug 14, 2018·1 cites·18 claims
- 3877US9956291B2Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targetingMOUSA SHAKER A·Filed 2013·Granted May 1, 2018·1 cites·20 claims
- 3977US9950091B2Composition and method for stopping hemorrhage, infection, and accelerating healing in various types of wound or burnsMOUSA DEENA S·Filed 2016·Granted Apr 24, 2018·4 cites·21 claims
- 4077US9381255B2Formulations comprising T3 nanoparticlesAVANT GARDE THERAPEUTICS AND TECHNOLOGIES LLC·Filed 2013·Granted Jul 5, 2016·2 cites·15 claims
- 4177US8980823B2Formulations of Factor VIIa inhibitors and utilityMOUSA SHAKER A·Filed 2013·Granted Mar 17, 2015·1 cites·22 claims
- 4276US9822190B2Compositions and method for anti-sickling of red blood cells in sickle cell diseaseMOUSA SHAKER A·Filed 2016·Granted Nov 21, 2017·1 cites·19 claims
- 4375US8440217B1Method and system with contact lens product for treating and preventing adverse eye conditionsEL-NAGGAR MAWAHEB M·Filed 2005·Granted May 14, 2013·17 cites·77 claims
- 4475US8314078B2Silver nanoparticles as anti-microbialMOUSA SHAKER A·Filed 2010·Granted Nov 20, 2012·3 cites·20 claims
- 4572US6908907B2Prevention and treatment of tumor growth, metastasis, and thromboembolic complications in cancer patientsFiled 2002·Granted Jun 21, 2005·4 cites·17 claims
- 4671US6114328AIsoxazoline and isoxazole fibrogen receptor antagonistsDU PONT PHARM CO·Filed 1997·Granted Sep 5, 2000·27 cites·49 claims
- 4768US11186551B2Composition of scalable thyrointegrin antagonists with improved retention in tumorsNANOPHARMACEUTICALS LLC·Filed 2021·Granted Nov 30, 2021·0 cites·12 claims
- 4867US12246089B2Method for treatment of a viral-mediated infectious diseaseVirothera Pharmaceuticals LLC·Filed 2021·Granted Mar 11, 2025·0 cites·20 claims
- 4967US10695436B2Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonistsNANOPHARMACEUTICALS LLC·Filed 2018·Granted Jun 30, 2020·0 cites·19 claims
- 5067US9480703B2Method and composition of glycosaminoglycans in sickle cell and vascular disordersMOUSA SHAKER A·Filed 2014·Granted Nov 1, 2016·0 cites·20 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shaker A. Mousa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →